We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
(Site Profile/Docket Number 040)
Location: Aliquippa, Pennsylvania
Also Known As: Vulcan Crucible Steel Co., Universal Cyclops, Inc.
The Special Exposure Cohort (SEC) is a unique category of employees established by the Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 “specified cancers,” and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.
Open/Active SEC Petitions
To date, there are no open/active SEC petitions from Aliquippa Forge.
If the energy employee’s personal radiation information is incomplete, NIOSH will use other sources to estimate the radiation dose. This may involve using technical documents called Site Profiles, Technical Basis Documents, and Technical Information Bulletins.
Technical Basis Documents
Basis for the Development of an Exposure Matrix for Aliquippa Forge, Pennsylvania, Period of Operation: January 1, 1947 through February 28, 1950 [482 KB (34 pages)]Revised November 16, 2015
Revision Includes: Revision initiated due to comments from the Advisory Board Subcommittee for Procedures Review. Residual period approach in Section 5.0 updated based on change in the treatment of an air sample from being treated as an operational air sample to a postoperational air sample. This resulted in a new source term depletion factor, internal intake rates, and external dose rates. Incorporates formal internal and NIOSH review comments.
Advisory Board and NIOSH Discussions on Aliquippa Forge
The Aliquippa Forge discussion papers listed below are working documents prepared by NIOSH or its contractor for use in discussions with the Advisory Board on Radiation and Worker Health or its Working Groups or Subcommittees. Draft, preliminary, interim, and white paper documents are not final NIOSH or Advisory Board (or their technical support and review contractors) positions unless specifically marked as such. These documents represent preliminary positions taken on technical issues prepared by NIOSH or its contractor.
The discussion papers have been reviewed to identify and redact any information that is protected by the Privacy Act 5 USC §552a and have been cleared for distribution.
SC&A Presentation: Review of One Advisory Board-Selected Case Reworked for the Evaluation of Aliquippa Forge Technical Basis Document Revisions (DCAS-PER-045, Subtask 4) [389 KB (17 pages)]
Presentation at the February 15, 2022, Teleconference Meeting of the Subcommittee for Procedure Reviews
SC&A Memo: Review of NIOSH’s Response to DCAS-PER-045 Findings [503 KB (12 pages)]
March 24, 2015
SC&A Draft: A Review of NIOSH’s Program Evaluation Report DCAS-PER-045, “Aliquippa Forge TBD Revision” [1.2 MB (33 pages)]
Contract No. 211-2014-58081
SCA-TR-PR2014-0092, Rev. 0
August 20, 2014
SC&A Draft: A Pre-Evaluation of DCAS-PER-041, DCAS-PER-042, DCAS-PER-043, DCAS-PER-044, and DCAS-PER-045 for a Formal Audit by SC&A [318 KB (9 pages)]
Contract No. 211-2014-58081
SCA-TR-PR2014-0003, Rev. 0
April 10, 2014
Program Evaluation Plans (PEPs) and Program Evaluation Reports (PERs)
NIOSH is committed to applying the best available science in dose reconstructions. In keeping with this commitment, completed cases with probabilities of causation less than 50% are reviewed as relevant new information becomes available. The results of these reviews are described in a Program Evaluation Report (PER). The PER details the effect, if any, of the new information on the completed dose reconstruction. If it appears that the new information may result in an increase in dose for a completed dose reconstruction with a probability of causation of less than 50%, NIOSH is committed to working with the Department of Labor to reopen and rework the dose reconstruction, as appropriate. A Program Evaluation Plan (PEP) describes plans for evaluating specific program details or issues.
To view all PERs and PEPs that have been developed, please refer to the Program Evaluation Reports (PERs) and Program Evaluation Plans (PEPs) page.
DCAS-PER-076 Rev-0: Aliquippa Forge Program Evaluation Report [29 KB (2 pages)]
February 15, 2017
About this Document: Determines the effect of the revision to ORAUT-TKBS-0021, (Aliquippa Forge) on previously completed claims.
Summary: A new dose estimate was performed for 21 claims using revision 2 of the TBD, as well as all other applicable approved dose reconstruction methods. The resulting probability of causation (POC) was below 45% for 20 claims. The one remaining claim resulted in a POC greater than 52%. NIOSH will provide the Department of Labor with the list of all claims evaluated under this PER and request the return of the one claim that would now result in a POC greater than 50%.
DCAS-PER-045 Rev-0: Program Evaluation Report: Aliquippa Forge TBD Revision [15 KB (1 page)]
May 13, 2013
About this Document: Evaluates all claims with employment in the residual period and a probability of causation less than 50% to determine the affect of the Aliquippa Forge TBD Revision 1.
Summary: Twenty six claims with a probability of causation less than 50% were previously completed. Five of those had no employment in the residual period and were eliminated from further review. The dose was estimated for the remaining twenty one claims using the Revision 1 of the TBD. All twenty one remaining claims resulted in a probability of causation below 45%.
Public Comments on Aliquippa Forge Documents
How to Submit Comments
Comments on Aliquippa Forge Documents can be submitted to the NIOSH Docket Officer electronically by email at firstname.lastname@example.org or printed comments can be mailed to:
NIOSH Docket Office
Robert A. Taft Laboratories, MS-C34
1090 Tusculum Avenue
Cincinnati, OH 45226
Please include the Site Profile/Docket Number (040) on all comments.
At this time, no comments have been submitted.
Document Archive for Aliquippa Forge
Basis for the Development of an Exposure Matrix for Aliquippa Forge, Pennsylvania, Period of Operation: January 1, 1947 through February 28, 1950
Revised April 26, 2012 [352 KB (32 pages)]
Revision Includes: Revision initiated due to comments from the Advisory Board Subcommittee on Dose Reconstruction. Residual period approach in Section 5.0 updated per ORAUT-OTIB-0070 and additional data capture information. Added an internal approach to account for decommissioning and decontamination operations in 1988 and 1993/1994. Incorporates formal internal and NIOSH review comments. Constitutes a total rewrite of the document.
Page Change Revision November 18, 2005 [283 KB (26 pages)]
Page Change Revision Includes: Modified to note the covered period and the period of operation on page 1, 19 and in Section 2.0 on page 5. Modified pages 20, 21, and 22 in response to comments and guidance from OCAS. Updated Section 1.0 (page 5) standard wording. No sections were deleted.